LT3372229T - Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai - Google Patents

Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai

Info

Publication number
LT3372229T
LT3372229T LTEP18169211.2T LT18169211T LT3372229T LT 3372229 T LT3372229 T LT 3372229T LT 18169211 T LT18169211 T LT 18169211T LT 3372229 T LT3372229 T LT 3372229T
Authority
LT
Lithuania
Prior art keywords
strengthening
treatment
methods
angelman syndrome
tone
Prior art date
Application number
LTEP18169211.2T
Other languages
English (en)
Inventor
Matthew During
Original Assignee
Ovid Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ovid Therapeutics, Inc. filed Critical Ovid Therapeutics, Inc.
Publication of LT3372229T publication Critical patent/LT3372229T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
LTEP18169211.2T 2014-06-06 2015-06-03 Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai LT3372229T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462008939P 2014-06-06 2014-06-06

Publications (1)

Publication Number Publication Date
LT3372229T true LT3372229T (lt) 2021-07-12

Family

ID=54767324

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP18169211.2T LT3372229T (lt) 2014-06-06 2015-06-03 Toninio slopinimo sustiprinimo ir angelmano sindromo gydymo būdai
LTEP15803364.7T LT3151832T (lt) 2014-06-06 2015-06-03 Toninio slopinimo sustiprinimo ir antrinės nemigos gydymo būdai

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP15803364.7T LT3151832T (lt) 2014-06-06 2015-06-03 Toninio slopinimo sustiprinimo ir antrinės nemigos gydymo būdai

Country Status (20)

Country Link
US (11) US20150352085A1 (lt)
EP (3) EP3372229B1 (lt)
JP (4) JP2017516868A (lt)
AR (1) AR100772A1 (lt)
AU (4) AU2015269667B2 (lt)
CA (1) CA2950845C (lt)
CY (2) CY1124366T1 (lt)
DK (2) DK3151832T3 (lt)
ES (2) ES2876350T3 (lt)
HR (2) HRP20210901T1 (lt)
HU (2) HUE055400T2 (lt)
IL (2) IL249287B (lt)
LT (2) LT3372229T (lt)
MX (2) MX391502B (lt)
PL (2) PL3372229T3 (lt)
PT (2) PT3372229T (lt)
RS (2) RS62006B1 (lt)
SI (2) SI3372229T1 (lt)
SM (2) SMT202100340T1 (lt)
WO (1) WO2015187851A1 (lt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6634626B2 (ja) 2013-11-05 2020-01-22 エレーナ モロカノヴァＥｌｅｎａ ＭＯＬＯＫＡＮＯＶＡ 受容体およびイオンチャネルの位置特異的サブタイプの調節のためのナノ構造物複合体
ES2876350T3 (es) 2014-06-06 2021-11-12 Ovid Therapeutics Inc Métodos para aumentar la inhibición tónica y tratamiento del insomnio secundario
US10080898B2 (en) 2015-05-29 2018-09-25 Medtronic, Inc. Simultaneous physiological sensing and stimulation with saturation detection
US10434308B2 (en) 2015-05-29 2019-10-08 Medtronic, Inc. Impedance matching and electrode conditioning in patient interface systems
US9682069B2 (en) 2015-07-17 2017-06-20 Ovid Therapeutics Inc Methods of treating Dravet syndrome
KR20240160666A (ko) 2015-07-17 2024-11-11 오비드 테라퓨틱스 인크. 가복사돌로 발달장애들을 치료하는 방법들
WO2018017639A1 (en) * 2016-07-19 2018-01-25 Georgia State University Research Foundation Methods for treating rett syndrome
EP4233861A3 (en) 2016-08-11 2023-10-11 Ovid Therapeutics, Inc. Compositions for treatment of essential tremor
JP2019535760A (ja) * 2016-11-22 2019-12-12 オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． フルピルチンを用いた発達障害および／または発作性障害の処置方法
US10071083B2 (en) * 2017-02-03 2018-09-11 Ovid Therapeutics Inc Use of gaboxadol in the treatment of tinnitus
US20180338959A1 (en) * 2017-05-24 2018-11-29 Ovid Therapeutics Inc. Treatment of depressive disorders
US10813918B2 (en) 2017-08-04 2020-10-27 Ovid Therapeutics Inc. Use of Gaboxadol in the treatment of diabetes and related conditions
US11181384B2 (en) * 2018-07-23 2021-11-23 Waymo Llc Verifying map data using challenge questions
AU2019345312A1 (en) 2018-09-20 2021-03-25 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of tourette syndrome, tics and stuttering
WO2020106927A1 (en) * 2018-11-21 2020-05-28 Certego Therapeutics Gaboxadol for reducing risk of suicide and rapid relief of depression
CN113423399A (zh) 2018-12-17 2021-09-21 奥维德医疗公司 加波沙朵用于治疗非24小时睡眠-觉醒障碍的用途
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
KR20220035195A (ko) * 2019-07-15 2022-03-21 오비드 테라퓨틱스 인크. 치료적 치료를 위한 가복사돌을 포함하는 약학적 제제
WO2021127308A1 (en) * 2019-12-18 2021-06-24 Ovid Therapeutics Inc. GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME
MX2022014599A (es) 2020-05-20 2022-12-16 Certego Therapeutics Inc Gaboxadol deuterado en anillo y su uso para el tratamiento de trastornos psiquiatricos.
JP7600661B2 (ja) * 2020-12-11 2024-12-17 ａｒｔｉｅｎｃｅ株式会社 貼付剤
JP2026506097A (ja) * 2023-02-17 2026-02-20 オービッド・セラピューティクス・インコーポレイテッド 多発性硬化症の処置における（ｓ）－３－アミノ－４－（ジフルオロメチレニル）シクロペント－１－エン－１－カルボン酸の使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK270278A (da) 1977-06-20 1978-12-21 Krogsgaard Larsen P Cycliske aminosyrer
US4362731A (en) 1980-09-01 1982-12-07 Sandoz Ltd. Myotonolytic use of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridin-3-ol and derivatives thereof
US4353910A (en) 1981-11-27 1982-10-12 Kefalas A/S Derivatives of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridine-3-one, pharmaceutical compositions and methods of treatment
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
DE19526864A1 (de) 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US6461644B1 (en) 1996-03-25 2002-10-08 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US6676961B1 (en) 2002-03-06 2004-01-13 Automated Carrier Technologies, Inc. Transdermal patch assembly
US20050137222A1 (en) * 2003-12-18 2005-06-23 H. Lundbeck A/S Treatment of insomnia in human patients
US20080269278A1 (en) 2004-04-02 2008-10-30 H. Lundbeck A/S Treatment of Impaired Respiratory Function with Gaboxadol
DE102005020882A1 (de) * 2005-05-04 2006-11-09 Dömling, Alexander, Dr. Verwendung von Gaboxadol und Derivaten zur Behandlung von Kinase-induzierten Krankheiten
US20110046090A1 (en) * 2005-10-31 2011-02-24 Braincells Inc. Modulation of neurogenesis with gaba agents and gaba analogs
US20090143335A1 (en) 2007-10-29 2009-06-04 H. Lundbeck A/S Modified absorption formulation of gaboxadol
CA2705733C (en) 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
CA2732636A1 (en) * 2008-09-01 2009-05-07 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat
ES2876350T3 (es) 2014-06-06 2021-11-12 Ovid Therapeutics Inc Métodos para aumentar la inhibición tónica y tratamiento del insomnio secundario
KR20240160666A (ko) * 2015-07-17 2024-11-11 오비드 테라퓨틱스 인크. 가복사돌로 발달장애들을 치료하는 방법들
US9399034B1 (en) 2015-08-11 2016-07-26 Ovid Therapeutics Inc Methods of sedation during critical care treatment

Also Published As

Publication number Publication date
AU2024202604A1 (en) 2024-05-09
HRP20210902T1 (hr) 2021-09-17
MX2016016136A (es) 2017-07-05
US20170273956A1 (en) 2017-09-28
EP3151832B1 (en) 2021-03-24
PT3151832T (pt) 2021-06-15
MX391502B (es) 2025-03-21
DK3151832T3 (da) 2021-06-14
PL3372229T3 (pl) 2021-10-04
RS62007B1 (sr) 2021-07-30
IL249287B (en) 2021-03-25
US9801864B2 (en) 2017-10-31
US20170087133A1 (en) 2017-03-30
US20180015076A1 (en) 2018-01-18
CA2950845C (en) 2023-04-25
WO2015187851A1 (en) 2015-12-10
JP2023123442A (ja) 2023-09-05
US9744159B2 (en) 2017-08-29
AU2022200085A1 (en) 2022-02-03
SI3151832T1 (sl) 2021-08-31
HRP20210901T1 (hr) 2021-09-17
US20150352085A1 (en) 2015-12-10
AR100772A1 (es) 2016-11-02
US20160228418A1 (en) 2016-08-11
CY1124368T1 (el) 2022-07-22
US20170071917A1 (en) 2017-03-16
LT3151832T (lt) 2021-07-12
US20220016091A1 (en) 2022-01-20
US20230051859A1 (en) 2023-02-16
EP3372229A1 (en) 2018-09-12
US11278529B2 (en) 2022-03-22
HUE055400T2 (hu) 2021-11-29
RS62006B1 (sr) 2021-07-30
EP3151832A1 (en) 2017-04-12
ES2876350T3 (es) 2021-11-12
CY1124366T1 (el) 2022-07-22
AU2015269667A1 (en) 2016-12-22
CA2950845A1 (en) 2015-12-10
IL268960A (en) 2019-10-31
EP3372229B1 (en) 2021-03-24
AU2020217342B2 (en) 2021-10-07
MX380868B (es) 2025-03-12
AU2015269667B2 (en) 2020-07-30
IL249287A0 (en) 2017-02-28
DK3372229T3 (da) 2021-06-14
HUE055155T2 (hu) 2021-11-29
PL3151832T3 (pl) 2021-10-25
SMT202100343T1 (it) 2021-07-12
MX2020012404A (es) 2022-04-11
SI3372229T1 (sl) 2021-09-30
IL268960B (en) 2021-05-31
EP3151832A4 (en) 2018-01-17
ES2875742T3 (es) 2021-11-11
JP2017516868A (ja) 2017-06-22
AU2020217342A1 (en) 2020-08-27
PT3372229T (pt) 2021-06-17
US20250025448A1 (en) 2025-01-23
EP3795156A1 (en) 2021-03-24
US9446028B2 (en) 2016-09-20
JP2021178836A (ja) 2021-11-18
US20160038469A1 (en) 2016-02-11
JP2020063264A (ja) 2020-04-23
US9339495B2 (en) 2016-05-17
US20180303805A1 (en) 2018-10-25
SMT202100340T1 (it) 2021-07-12

Similar Documents

Publication Publication Date Title
IL284727B (en) Noise suppression methods and apparatus
LT3151832T (lt) Toninio slopinimo sustiprinimo ir antrinės nemigos gydymo būdai
IL249292A0 (en) Methods and devices for treating pulmonary edema
IL269371A (en) Treatment methods
IL252602B (en) Oral care compositions and methods of use
IL253463A0 (en) Binding-triggered transcriptional switches and methods of use thereof
LT3653221T (lt) Anti-pvrig antikūnai ir naudojimo būdai
LT3179991T (lt) Terapiniai btk inhibitoriaus ir bcl-2 inhibitoriaus deriniai
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
PL3402888T3 (pl) Środki i sposoby leczenia hbv
LT3212189T (lt) Pakeisti chromanai ir naudojimo būdas
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
PL3212174T3 (pl) Sposoby leczenia zakażeń wirusem filoviridae
DK3129018T3 (da) Behandling af NAFLD og NASH
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3227675T3 (da) Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom
LT3514151T (lt) Proteinkinazės c inhibitoriai ir jų naudojimo būdai
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
ZA201706257B (en) Treatment of wood
EP3324961C0 (en) TREATMENT OF ANGELMAN SYNDROME WITH GABOXADOL
LT3122359T (lt) Fgfr inhibitoriaus ir igf1r inhibitoriaus deriniai
LT3341027T (lt) Transfekcijos kompleksai ir jų panaudojimo būdai
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom